Protalix BioTherapeutics
PLX
#8656
Rank
ยฃ0.10 B
Marketcap
ยฃ1.36
Share price
-1.72%
Change (1 day)
-2.64%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ21.79 Million

According to Protalix BioTherapeutics 's latest financial reports the company has ยฃ21.79 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ34.97 M90.78%
2022-12-31ยฃ18.33 M-36.52%
2021-12-31ยฃ28.88 M2.13%
2020-12-31ยฃ28.27 M108.42%
2019-12-31ยฃ13.56 M-54.45%
2018-12-31ยฃ29.78 M-21.32%
2017-12-31ยฃ37.85 M-26.18%
2016-12-31ยฃ51.28 M-0.49%
2015-12-31ยฃ51.53 M46.51%
2014-12-31ยฃ35.17 M-32.84%
2013-12-31ยฃ52.37 M62.69%
2012-12-31ยฃ32.19 M85.32%
2011-12-31ยฃ17.37 M-25.3%
2010-12-31ยฃ23.25 M-53.69%
2009-12-31ยฃ50.21 M72.79%
2008-12-31ยฃ29.06 M-6.59%
2007-12-31ยฃ31.11 M165.5%
2006-12-31ยฃ11.71 M326.26%
2005-12-31ยฃ2.74 M835.82%
2004-12-31ยฃ0.29 M-28.19%
2003-12-31ยฃ0.4 M-18.78%
2002-12-31ยฃ0.5 M-20.24%
2001-12-31ยฃ0.63 M-41.38%
2000-12-31ยฃ1.07 M18.49%
1999-12-31ยฃ0.9 M17.25%
1998-12-31ยฃ0.77 M132.49%
1997-12-31ยฃ0.33 M-25.24%
1996-12-31ยฃ0.44 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.19 B 811.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.97 B 4,380.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.91 B 36,209.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.63 B 12,009.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel